| Nov 6 |
Verve Therapeutics Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 5 |
Verve Therapeutics (VERV) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 5 |
Verve Therapeutics beats Q3 estimates
|
| Nov 5 |
Verve Therapeutics: Q3 Earnings Snapshot
|
| Nov 5 |
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results
|
| Oct 16 |
State Street Corp's Strategic Acquisition in Verve Therapeutics
|
| Oct 3 |
Is Verve Therapeutics, Inc. (VERV) the Best NASDAQ Stock Under $5?
|
| Sep 20 |
Jim Cramer on Verve Therapeutics Inc. (VERV): ‘I Think It’s A Winner’
|
| Sep 12 |
Millennium Management LLC's Strategic Acquisition in Verve Therapeutics Inc
|
| Sep 8 |
Verve Therapeutics, Inc. (VERV): Among the Worst ARK Stocks According to Short Sellers
|
